172 related articles for article (PubMed ID: 36971046)
1. Clinical and pathological features analysis of invasive breast cancer with microcalcification.
Tian Y; Zhao L; Gui Z; Liu S; Liu C; Yu T; Zhang L
Cancer Med; 2023 May; 12(10):11351-11362. PubMed ID: 36971046
[TBL] [Abstract][Full Text] [Related]
2. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
Yamamoto Y; Ibusuki M; Okumura Y; Kawasoe T; Kai K; Iyama K; Iwase H
Breast Cancer Res Treat; 2008 Aug; 110(3):465-75. PubMed ID: 17805961
[TBL] [Abstract][Full Text] [Related]
4. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
5. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
6. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.
Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727
[TBL] [Abstract][Full Text] [Related]
8. Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.
Nalwoga H; Ahmed L; Arnes JB; Wabinga H; Akslen LA
PLoS One; 2016; 11(1):e0146823. PubMed ID: 26760782
[TBL] [Abstract][Full Text] [Related]
9. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
[TBL] [Abstract][Full Text] [Related]
10. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Intracellular Transcription of Factors HIF-1α and p53 and Their Relation to Estradiol and TNM Parameters of Breast Cancer Tissues in Women with Invasive Ductal Carcinoma in Thi-Qar Province, Iraq.
Ali Khadem Z; Abdul Wadood Al-Shammaree S
Arch Razi Inst; 2022 Aug; 77(4):1341-1348. PubMed ID: 36883155
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
[TBL] [Abstract][Full Text] [Related]
14. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
[TBL] [Abstract][Full Text] [Related]
15. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.
Dong M; Wan XB; Yuan ZY; Wei L; Fan XJ; Wang TT; Lv YC; Li X; Chen ZH; Chen J; Lin Q; Wen JY; Ma XK; Liu Q; Wu XY
Med Oncol; 2013 Mar; 30(1):355. PubMed ID: 23408367
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced factor-1 alpha, vascular endothelial growth factor expression in BRCA1-related breast cancer: A prospective study in tertiary care hospital.
Sharma M; Piplani S; Madan M; Manjari M; Garg S; Kaur K
Indian J Pathol Microbiol; 2017; 60(4):469-474. PubMed ID: 29323057
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G;
Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Pansare V; Munkarah AR; Schimp V; Haitham Arabi M; Saed GM; Morris RT; Ali-Fehmi R
Mod Pathol; 2007 Jan; 20(1):35-43. PubMed ID: 17099695
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
